EOLS Evolus, Inc.
$7.97
Evolus, Inc. (EOLS) is expected to report earnings on November 5, 2026, after the market close. The consensus earnings estimate is a loss of $0.14 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +14.0% since its last earnings release on August 5, 2026.
Evolus Missed Expectations, Narrows Guidance Above Estimates
Wednesday, August 5, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 5
Thursday · 4:05 PM ET
Earnings Whisper
-
vs ($0.14)
(GAAP)
Rev est $77.09M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$8.31
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Evolus, Inc.
Evolus is a performance beauty company with a customer-centric approach focused on delivering breakthrough products.
Sector
Healthcare
Industry
Medical Instruments/Supply
Charts powered in part by Lightweight Charts™ by TradingView.